GDF2 and neoplasm: Although our in vitro assays support a direct inhibitory effect of BMP9 on the abnormal tumour vasculature, we cannot exclude the pro‐growth effect of BMP9 on our in vivo tumour model, in which increased tumour growth was observed for BMP9‐expressing HepG2.2.15 cells (Figure 6C).